The legacy of Viagra and its parent , copyright, presents a tangled picture for cautious investors. While the blockbuster drug initially fueled enormous earnings, its protection has ended, leading to competing alternatives flooding the market . This reduction in value presents a substantial challenge for copyright and any company considering a heav